[11 June 2013]
Products Affected - Description
Dextrose Injection 50%, Amphastar (IMS)
50 mL Luer-Jet syringes (NDC 00548-3301-01)
Dextrose Injection 50%, Hospira
50 mL vial, 25 count (NDC 00409-6648-02)
50 mL Lifeshield syringe, 10 count (NDC 00409-4902-34)
50 mL Ansyr II Luer-lock syringe, 10 count (NDC 00409-7517-16)
Reason for the Shortage
- Hospira states the shortage is due to increased demand.
- Amphastar has a shortage of dextrose 50% syringes due to increased demand for the product.
Available Products
There are no presentations readily available.
Estimated Resupply Dates
- Hospira has dextrose injection 50% Ansyr II Luer-lock syringes, 50 mL Lifeshield syringes, and 50 mL vials on back order and the company estimates a release date of mid-June 2013 for the Lifeshield syringes and early-July 2013 for the 50 mL vials and Ansyr II syringes.
- Amphastar (IMS) has dextrose injection 50% 50 mL Luer-Jet syringes on intermittent back order and the company is releasing product regularly.
Related Shortages
Updated
June 11, 2013; May 30, 2013; May 15, 2013; April 29, 2013; April 1, 2013; March 11, 2013; February 22, 2013; February 8, 2013; January 21, 2013; November 30, 2012; October 24, 2012; August 9, 2012; June 27, 2012; May 24, 2012; May 23, 2012; May 4, 2012; March 29, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins